Search research articles
Contact Us
Filters
Showing results (281-290 of 425) with videos related to
Page
of 43
Sort By:
Human Vaccines & Immunotherapeutics
|
March 28, 2022
Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age
Anna Lisa Ong-Lim, Georgi Shukarev, Mitzi Trinidad-Aseron, et al.
Neuro-Oncology
|
July 7, 2016
Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients
Kourosh Jafari-Khouzani, Franziska Loebel, Wolfgang Bogner, et al.
Acta Neuropathologica Communications
|
January 7, 2021
Sporadic multiple meningiomas harbor distinct driver mutations
Tareq A Juratli, Insa Prilop, Felix C Saalfeld, et al.
Journal of Neurosurgery
|
November 26, 2016
Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas
Matthew R Strickland, Corey M Gill, Naema Nayyar, et al.
Nature Communications
|
August 16, 2024
Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas
Syeda Maheen Batool, Ana K Escobedo, Tiffaney Hsia, et al.
Cancer Research
|
June 20, 2017
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i>-Mutant Cancers and Potentiates NAD<sup>+</sup> Depletion-Mediated Cytotoxicity
Kensuke Tateishi, Fumi Higuchi, Julie J Miller, et al.
Journal of Neuro-Oncology
|
October 21, 2024
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design
Ethan A Wetzel, Amin I Nohman, Annie L Hsieh, et al.
Cancer
|
July 18, 2019
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations
Tareq A Juratli, Pamela S Jones, Nancy Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2015
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
Ovidiu C Andronesi, Franziska Loebel, Wolfgang Bogner, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
December 27, 2021
In Vivo Absolute Metabolite Quantification Using a Multiplexed ERETIC-RX Array Coil for Whole-Brain MR Spectroscopic Imaging
Bijaya Thapa, Azma Mareyam, Jason Stockmann, et al.
Page
of 43
Search research articles
Search
Showing results (281-290 of 425) with videos related to
Sort By:
Page
of 43
Human Vaccines & Immunotherapeutics
|
March 28, 2022
Safety and immunogenicity of 3 formulations of a Sabin inactivated poliovirus vaccine produced on the PER.C6® cell line: A phase 2, double-blind, randomized, controlled study in infants vaccinated at 6, 10 and 14 weeks of age
Anna Lisa Ong-Lim, Georgi Shukarev, Mitzi Trinidad-Aseron, et al.
Neuro-Oncology
|
July 7, 2016
Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients
Kourosh Jafari-Khouzani, Franziska Loebel, Wolfgang Bogner, et al.
Acta Neuropathologica Communications
|
January 7, 2021
Sporadic multiple meningiomas harbor distinct driver mutations
Tareq A Juratli, Insa Prilop, Felix C Saalfeld, et al.
Journal of Neurosurgery
|
November 26, 2016
Targeted sequencing of SMO and AKT1 in anterior skull base meningiomas
Matthew R Strickland, Corey M Gill, Naema Nayyar, et al.
Nature Communications
|
August 16, 2024
Clinical utility of a blood based assay for the detection of IDH1.R132H-mutant gliomas
Syeda Maheen Batool, Ana K Escobedo, Tiffaney Hsia, et al.
Cancer Research
|
June 20, 2017
The Alkylating Chemotherapeutic Temozolomide Induces Metabolic Stress in <i>IDH1</i>-Mutant Cancers and Potentiates NAD<sup>+</sup> Depletion-Mediated Cytotoxicity
Kensuke Tateishi, Fumi Higuchi, Julie J Miller, et al.
Journal of Neuro-Oncology
|
October 21, 2024
A multi-center, clinical analysis of IDH-mutant gliomas, WHO Grade 4: implications for prognosis and clinical trial design
Ethan A Wetzel, Amin I Nohman, Annie L Hsieh, et al.
Cancer
|
July 18, 2019
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations
Tareq A Juratli, Pamela S Jones, Nancy Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 5, 2015
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate
Ovidiu C Andronesi, Franziska Loebel, Wolfgang Bogner, et al.
Journal of Magnetic Resonance Imaging : JMRI
|
December 27, 2021
In Vivo Absolute Metabolite Quantification Using a Multiplexed ERETIC-RX Array Coil for Whole-Brain MR Spectroscopic Imaging
Bijaya Thapa, Azma Mareyam, Jason Stockmann, et al.
Page
of 43